Upgrade to SI Premium - Free Trial

Aprea Therapeutics (APRE)

0.52 -0.02 (3.70%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/5/26)

Latest Headlines

Aprea Therapeutics to Host Pre-ESMO Virtual Panel on the State of WEE1 Inhibition in Precision Oncology October 16, 2026 8:30 AM - StreetInsider Ladenburg Thalmann Starts Aprea (APRE) at Buy October 14, 2026 6:42 AM - StreetInsider Aprea Therapeutics to Present at October Conferences October 5, 2026 8:30 AM - StreetInsider Aprea to present Phase 1 data on APR-1051 at EORTC-NCI-AACR symposium September 22, 2026 8:30 AM - StreetInsider Aprea Therapeutics to Present Updated Interim Phase 1 Data on WEE1 Inhibitor APR-1051 in an Oral Presentation at 38th EORTC-NCI-AACR Symposium September 22, 2026 8:30 AM - StreetInsider Aprea Therapeutics to Present at H.C. Wainwright 28th Annual Global Investment Conference September 10, 2026 8:00 AM - StreetInsider Form 8-K Aprea Therapeutics, Inc. For: Aug 28 August 28, 2026 8:30 AM - SEC Filing Aprea Therapeutics updates patent portfolio to 28 issued patents August 28, 2026 8:16 AM - StreetInsider Aprea Therapeutics Announces Expansion of Intellectual Property Portfolio for Precision Oncology Programs August 28, 2026 8:15 AM - StreetInsider Form SCHEDULE 13G/A Aprea Therapeutics, Inc. Filed by: LYTTON LAURENCE W August 13, 2026 2:27 PM - SEC Filing Form 10-Q Aprea Therapeutics, Inc. For: Jun 30 August 12, 2026 8:41 AM - SEC Filing Form 8-K Aprea Therapeutics, Inc. For: Aug 12 August 12, 2026 8:35 AM - SEC Filing Aprea Therapeutics Announces Second Quarter 2026 Financial Results August 12, 2026 8:30 AM - StreetInsider Lipocine names former Johnson & Johnson executive to its board August 3, 2026 8:00 AM - StreetInsider Lipocine Appoints Michael J. Grissinger to Board of Directors August 3, 2026 8:00 AM - PR NewsWire Aprea expands cancer trial sites and plans Q4 2026 data update July 30, 2026 8:01 AM - StreetInsider Aprea Therapeutics Provides ACESOT-1051 Program Update for WEE1 Inhibitor APR-1051: Accelerating and Expanding Enrollment. Clinical Data Presentation Planned for Q4 2026 July 30, 2026 8:00 AM - StreetInsider Full Article List